METABOLISM, PLASMA OR SERUM LEVELS, AND ELIMINATION OF PHENFORMIN IN GUINEA-PIGS, RATS, AND DOGS

被引:3
作者
ALKALAY, D
VOLK, J
ROTH, W
KHEMANI, L
BARTLETT, MF
机构
[1] Research Department, Pharmaceuticals Division, Ciba-Geigy Corporation, Ardsley, New York
关键词
Ant idiabetic agents—phenformin; metabolism; plasma or serum levels; and elimination in guinea pigs; rats; and dogs; TLC‐autoradiographic analysis; Autoradiography‐TLC—analysis; phenformin in biological fluids; Elimination—phenformin in guinea pigs; Metabolism—phenformin in guinea pigs; Phenformin—metabolism; Plasma or serum levels—phenformin in guinea pigs; TLC‐autoradiography—analysis;
D O I
10.1002/jps.2600680209
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
14C‐Phenformin hydrochloride was used for investigating the metabolism, plasma or serum levels, and elimination of the drug following 1.5‐mg/kg po or iv doses to guinea pigs, rats, and dogs. The amounts of individual metabolites and unchanged drug were assessed in urine as well as in plasma or serum. The glucuronide of 1‐(p‐hydroxyphenethyl)biguanide was a major metabolite in the blood and urine of all three species. Guinea pig serum and urine contained a sizable quantity of unchanged drug. Dog plasma and urine had significant amounts of nonconjugated 1‐(p‐hydroxyphenethyl)biguanide and of an unidentified major metabolite. In all three species following intravenous drug administration, unchanged drug contributed significantly to the radioactivity found in blood and urine. The apparent half‐lives of phenformin elimination were 0.3‐0.8 day for guinea pigs and rats and 1‐1.5 days for dogs. Urinary excretion data indicate apparent half‐lives of approximately 1.3‐1.5 days for the elimination of each of the three major metabolites in dogs. Copyright © 1979 Wiley‐Liss, Inc., A Wiley Company
引用
收藏
页码:156 / 160
页数:5
相关论文
共 8 条
[1]   CONVERSION OF BIGUANIDES INTO SUBSTITUTED S-TRIAZINES ASSAYABLE BY GC OR MASS FRAGMENTOGRAPHY [J].
ALKALAY, D ;
VOLK, J ;
BARTLETT, MF .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1976, 65 (04) :525-529
[2]   PHARMACOKINETICS OF PHENFORMIN IN MAN [J].
ALKALAY, D ;
KHEMANI, L ;
WAGNER, WE ;
BARTLETT, MF .
JOURNAL OF CLINICAL PHARMACOLOGY, 1975, 15 (5-6) :446-448
[3]   FATE OF BIGUANIDES IN MAN [J].
BECKMANN, R .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1968, 148 (A3) :820-&
[4]  
Beckmann R, 1967, Diabetologia, V3, P368, DOI 10.1007/BF02342630
[5]  
CONWAY WD, 1968, J PHARM SCI, V57, P1134
[6]   DRUG URINARY EXCRETION DATA - SOME ASPECTS CONCERNING INTERPRETATION [J].
MARTIN, BK .
BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1967, 29 (02) :181-&
[7]   SIMPLE ELECTRON-CAPTURE GAS-CHROMATOGRAPHIC METHOD FOR DETERMINATION OF ORAL HYPOGLYCEMIC BIGUANIDES IN BIOLOGICAL-FLUIDS [J].
MATIN, SB ;
KARAM, JH ;
FORSHAM, PH .
ANALYTICAL CHEMISTRY, 1975, 47 (03) :545-548
[8]   METABOLISM OF BETA-PHENETHYLBIGUANIDE [J].
MURPHY, PJ ;
WICK, AN .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1968, 57 (07) :1125-&